Albireo Pharma Inc Beta
Qual é o Beta de Albireo Pharma Inc?
O Beta de Albireo Pharma Inc é 0.00
Qual é a definição de Beta?
BETA indica se uma ação é mais ou menos volátil do que o mercado como um todo. Um beta menor que 1 indica que o estoque é menos volátil do que o mercado, enquanto um beta maior que 1 indica que o estoque é mais volátil. A volatilidade é medida como a flutuação do preço em torno da média.
Beta is a measure of the risk arising from exposure to general market movements as opposed to idiosyncratic factors. The market portfolio of all investable assets has a beta of exactly 1. A beta below 1 can indicate either an investment with lower volatility than the market, or a volatile investment whose price movements are not highly correlated with the market. A beta greater than one generally means that the asset both is volatile and tends to move up and down with the market. Beta is important because it measures the risk of an investment that cannot be reduced by diversification. It does not measure the risk of an investment held on a stand-alone basis, but the amount of risk the investment adds to an already-diversified portfolio. In the capital asset pricing model, beta risk is the only kind of risk for which investors should receive an expected return higher than the risk-free rate of interest.
Beta de empresas na Setor Health Care em NASDAQ em comparação com Albireo Pharma Inc
O que Albireo Pharma Inc faz?
Albireo Pharma is a clinical-stage biopharmaceutical company focused on the development of novel bile acid modulators to treat rare pediatric and adult liver diseases, and other adult liver diseases and disorders. Albireo's lead product candidate, odevixibat, is being developed to treat rare pediatric cholestatic liver diseases with Phase 3 pivotal trials in PFIC, Alagille syndrome and biliary atresia. The Company completed IND-enabling studies for new preclinical candidate A3907 this year and plans to advance development in adult liver disease. Albireo was spun out from AstraZeneca in 2008 and is headquartered in Boston, Massachusetts, with its key operating subsidiary in Gothenburg, Sweden. The Boston Business Journal named Albireo one of the 2020 Best Places to Work in Massachusetts for the second consecutive year.
Empresas com beta semelhantes a Albireo Pharma Inc
- Vision Marine Technologies tem Beta de 0.00
- Ely Gold Royalties tem Beta de 0.00
- Glacier Lake Resources tem Beta de 0.00
- Magnum Mining and Exploration tem Beta de 0.00
- Africa Opportunity Fund tem Beta de 0.00
- Fulcrum Utility Services tem Beta de 0.00
- Albireo Pharma Inc tem Beta de 0.00
- Gullewa tem Beta de 0.00
- S.A.L. Steel tem Beta de 0.00
- Andina Acquisition III tem Beta de 0.00
- Andina Acquisition III tem Beta de 0.00
- Brilliant Acquisition tem Beta de 0.00
- Indokem tem Beta de 0.00